Arm I: Attention Bias Modification (ABM) Training vs Arm II: Sham Training: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.0323 | 0.0126 | 0.08 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.0164 | 0.00451 | 0.0578 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.0159 | -0.03 | 0.0651 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.97 | 0.367 | 10.5 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 2 | 0.36 | 11.1 | log | ClinicalTrials.gov | |
| Number needed to harm, for one more participant with a serious adverse event on Arm I: Attention Bias Modification (ABM) Training than on Arm II: Sham Training | 63 | from the risk difference interval | the interval includes no difference | ClinicalTrials.gov |
Groups 2
Group 2 names the comparator: sham.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Arm I: Attention Bias Modification (ABM) Training | Patients receive ABM training over 30 minutes through a smartphone on days 1-14. Patients then receive nicotine patches for up to 8 weeks. | 4 | 124 | EG000 | ClinicalTrials.gov |
| Group 2 | Arm II: Sham Training | Patients undergo sham training on days 1-14. Patients then receive nicotine patches for up to 8 weeks. | 2 | 122 | EG001 | ClinicalTrials.gov |
Harm 2
| Field | Value | Source |
|---|---|---|
| What it counts | Total, serious adverse events | ClinicalTrials.gov |
| Time frame | 12 weeks | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking | ClinicalTrials.gov |
| NCT number | NCT02224391 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Current Every Day Smoker | ClinicalTrials.gov |
| Interventions | Computer-Assisted Smoking Cessation Intervention, Laboratory Biomarker Analysis, Nicotine Patch, Questionnaire Administration, Sham Intervention | ClinicalTrials.gov |
| Lead sponsor | M.D. Anderson Cancer Center | ClinicalTrials.gov |
| Results first posted | 2022-09-28 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT02224391?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.